Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$1.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,254
52-wk High
$4.40
52-wk Low
$1.29

Chart for

About

Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor... (more)

Overall

Beta: 3.66
Market Cap(Mil.): $18.12
Shares Outstanding(Mil.): 12.00
Dividend: --
Yield (%): --

Financials

  CYCC.OQ Industry Sector
P/E (TTM): -- 248.83 34.14
EPS (TTM): -1.70 -- --
ROI: -43.41 -5.25 13.10
ROE: -88.15 -6.83 15.09

BRIEF-Cyclacel Pharmaceuticals Reports Q1 Loss Per Share $0.12

* CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 14 2018

BRIEF-Cyclacel Pharmaceuticals Posts Qtrly Loss Of $2.1 Mln

* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 28 2018

BRIEF-Cyclacel Pharma Projects Cash Resources To Fund Currently Planned Programs Through End Of 2019

* CYCLACEL PHARMACEUTICALS INC - CO PROJECTS CASH RESOURCES TO FUND CURRENTLY PLANNED PROGRAMS THROUGH END OF 2019 Source text for Eikon: Further company coverage:

Jan 09 2018

Competitors

Earnings vs. Estimates